The Bombay Stock Exchange (BSE) said today that pharma major Dr Reddy's Laboratories will replace DLF in the benchmark 30-share Sensex.
The change will come into effect from June 11, 2012.
Besides Sensex, there will also be revisions in sectoral as well as BSE-100, BSE-200 and BSE-500, the exchange said in a statement.
According to the statement, the average free-float market capitalisation of Dr Reddy's stood at Rs 20,992.03 crore in the three months ended March. During the same period, the m-cap for DLF was Rs 8,893.58 crore.
In the BSE-100 index, Godrej Consumer Products will replace Glaxosmithkline Pharmaceuticals.
Meanwhile, in the BSE-200 index, Indiabulls Real Estate and Britannia Industries will replace Shipping Corporation of India and Alstom Projects India, respectively.
Two other companies, Hexaware Technologies and Stride Arcolab, will also make their entry into BSE-200. Hexaware Technologies and Stride Arcolab will replace India Securities and Bombay Rayon Fashions, respectively.
